Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL https://www.globenewswire.com/news-release/2024/06/06/2894525/0/en/Zealand-Pharma-announces-that-Boehringer-Ingelheim-will-present-positive-results-from-Phase-2-trial-with-survodutide-in-MASH-at-EASL.html company announcement